ACC 2026 Investor Update

Join Boston Scientific Cardiovascular leadership at the American College of Cardiology Scientific Session 2026 in New Orleans for an investor update on our cardiovascular innovation pipeline and latest clinical evidence.

The session covers key data readouts including CHAMPION-AF positioning WATCHMAN FLX as an alternative to NOACs for first-line stroke prevention, HI-PEITHO outcomes for the EKOS Endovascular System in intermediate-risk pulmonary embolism, and upcoming data across AF Solutions, Interventional Cardiology & Vascular Therapies, Cardiac Rhythm Management, and Interventional Oncology.

Featured speakers: Dr. Ken Stein (SVP & CMO), Dr. Michael R. Jaff (VP & CMO Vascular Therapies), Dr. Brad Sutton (CMO AF Solutions).